SHPCX Mutual Fund
SHPCX Mutual Fund
SHPCX Mutual Fund
Saratoga Health & Biotechnology Portfolio Class C
SHPCX Mutual Fund Overview
SHPCX Mutual Fund (Saratoga Health & Biotechnology Portfolio Class C) is managed by Saratoga Capital Management, LLC with $328,089.33 in net assets. SHPCX expense ratio is 3.60%, holding 30 positions across sectors including Health Care, Financials. Inception date: 2000-01-18.
SHPCX performance shows a YTD return of 6.64%. The 1-year return is 27.57% and the 5-year return is 4.98%. SHPCX dividend yield stands at 5.22%, paid annually.
SHPCX top holdings include Cardinal Health Inc. (7.3%), Jazz Pharmaceuticals Plc. (6.0%), United Therapeutics Corp (5.7%), Amgen Inc. (5.1%), Lantheus Holdings Inc (4.9%). Go to all SHPCX holdings, SHPCX sectors, or SHPCX dividends.
SHPCX can be compared against other funds. Use SHPCX overlap to find shared positions, or SHPCX vs another fund for a side-by-side view. SHPCX alternatives are available via the screener, along with tax-loss harvesting opportunities.